Category Archives for "News"

Abattis regains 100% ownership in Northern Vine to focus and expand on Lab and Extraction strategy

Abattis regains 100% ownership in Northern Vine to focus and expand on Lab and Extraction strategy SEPTEMBER 26, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce it has signed a settlement agreement returning 100% ownership in its laboratory subsidiary, Northern Vine Canada Inc. (“Northern […]

Read More

Abattis provides important update on Northern Vine and Sales Division

Abattis provides important update on Northern Vine and Sales Division SEPTEMBER 13, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an important update regarding its subsidiaries Northern Vine Canada Inc. (“Northern Vine”) and Vergence Naturals Ltd. (“Vergence”). “We are very pleased with the continued […]

Read More

Abattis Announces Breakthrough CBD-Based Sunscreen Formulation

Abattis Announces Breakthrough CBD-Based Sunscreen Formulation AUGUST 28, 2017    |    Abattis Bioceuticals VANCOUVER, British Columbia, Aug. 28, 2017 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce a breakthrough CBD-based sunscreen formulation, developed by Abattis through its majority-owned subsidiary, Northern Vine Canada Inc. (“Northern Vine”), and […]

Read More

Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets

Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets AUGUST 23, 2017    |    Abattis Bioceuticals VANCOUVER, British Columbia, — Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to provide an update on its subsidiary, Northern Vine Canada Inc. (“Northern Vine”), which specializes in the legal testing and analysis of cannabis […]

Read More

Abattis Announces Receipt of Cultivation License by LP Partner

Abattis Announces Receipt of Cultivation License by LP Partner AUGUST 21, 2017    |    Abattis Bioceuticals Abattis Bioceuticals Corp. (the ”Company“ or ”Abattis“) (CSE:ATT) (OTC:ATTBF) and its majority-owned testing and laboratory subsidiary, Northern Vine Canada Inc. (“Northern Vine”), are pleased to announce that their Licensed Producer (LP) investment partner, Experion Biotechnologies Inc. (“Experion”), has […]

Read More